Targeting novel signaling pathways for resistant acute myeloid leukemia. - Wikidata - wikimedia - TriplyDB

Targeting novel signaling pathways for resistant acute myeloid leukemia.

Targeting novel signaling pathways for resistant acute myeloid leukemia.

http://www.wikidata.org/entity/Q38297507

about

Drugging the unfolded protein response in acute leukemias Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemia Dynamics of ceramide generation and metabolism in response to fenretinide--Diversity within and among leukemia ALOX5 exhibits anti-tumor and drug-sensitizing effects in MLL-rearranged leukemia.Glycyrrhizic acid inhibits leukemia cell growth and migration via blocking AKT/mTOR/STAT3 signaling.Small molecule activation of NOTCH signaling inhibits acute myeloid leukemia.The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents.Merestinib blocks Mnk kinase activity in acute myeloid leukemia progenitors and exhibits antileukemic effects in vitro and in vivo.p70S6K promotes IL-6-induced epithelial-mesenchymal transition and metastasis of head and neck squamous cell carcinoma.Niclosamide inhibition of STAT3 synergizes with erlotinib in human colon cancer.Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia.A Predictive Based Regression Algorithm for Gene Network Selection.Neuropilin-1 contributes to esophageal squamous cancer progression via promoting P65-dependent cell proliferation.A loss-of-function genetic screening reveals synergistic targeting of AKT/mTOR and WTN/β-catenin pathways for treatment of AML with high PRL-3 phosphatase.SETDB2 Links E2A-PBX1 to Cell-Cycle Dysregulation in Acute Leukemia through CDKN2C Repression.

P2860

Q26801114-C062B772-DA27-47CB-9D64-A88FF1A82094 Q30276873-3A8BB738-C53C-43F4-98C3-71A76E2B245E Q30278944-E92F4AC4-D295-4A27-9D36-CFA508B0DAB6 Q33687080-DA35B5CD-4265-4EFC-9C3A-4898E6C9DDF5 Q35854097-B336DED9-7898-43EC-A923-5BFDE1A96652 Q36925443-C12F147A-BEEE-4918-BB72-9DF208A3C5AC Q36997966-E62373F6-2984-4355-8320-0A84C11F724C Q37117628-E0615BC9-EFD8-4673-BB42-66F588253782 Q37392765-9681DE9B-9919-4ACB-8E65-3D104E8826EC Q37725643-C11CB7EA-274B-451A-89A5-A2B7E389F31E Q38722849-BB5BB690-33EE-4881-B5B2-B0D650630B77 Q39631174-E842B875-8466-4703-8F89-EBCAEBB11D31 Q47616434-B3599FC5-6711-4366-BA2D-867B976C25DE Q52668830-E1534FCD-3DAF-4811-8084-923DBED5C512 Q52716748-16F77A81-20AC-49D3-AFCE-CCE53A9BC725

P2860

Targeting novel signaling pathways for resistant acute myeloid leukemia.

http://www.wikidata.org/entity/Q38297507

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Targeting novel signaling pathways for resistant acute myeloid leukemia.

@en

type

label

Targeting novel signaling pathways for resistant acute myeloid leukemia.

@en

prefLabel

Targeting novel signaling pathways for resistant acute myeloid leukemia.

@en

P1433

Q38297507-2D846DE3-ADF7-4B47-9DFC-79221D8A80BB

P1476

Q38297507-C6C9372A-6B06-45EE-8690-15658E5847C9

P2093

Q38297507-09000D78-E6BF-41FF-B8CC-1E7B58089E8E

Q38297507-39FFD48A-4742-46AD-BEE6-CC0B349732E6

Q38297507-516961E6-B46D-4F25-AAE8-80A7D3D4867C

Q38297507-6002016C-0FF8-4DD7-A992-44B52B36279A

Q38297507-6D9818AA-BA20-439B-98B8-FCB2ACBEC98B

Q38297507-83CA6057-C010-4EE7-9D58-D19FF00C7399

Q38297507-ACFF0358-9BB1-4C0B-8D6B-183790BFA71C

P2860

Q38297507-04C6CFB4-97EE-4255-8BF8-1F511AABDB29

Q38297507-08530B51-F7E7-46C8-A971-CDEB335F8D6A

Q38297507-0B2AD455-C523-4B56-9296-AF71E968B4C8

Q38297507-0EE99EB0-C414-4922-9C4E-5028E97A77A5

Q38297507-0FCC5979-72DF-44A9-BEDB-ECE97D72BBCB

Q38297507-10253EEA-B4FF-4477-9CA2-E97C3AD7EFC7

Q38297507-1899C645-AD46-416C-B0E4-B736B2318B27

Q38297507-1C4C454B-85E5-4390-990D-F34DB7CE20FE

Q38297507-1D83944E-A6E2-4757-B8BA-9D23AE6E1CDB

Q38297507-22421BB4-F14E-4F3F-9655-EA249A8ACB12

P304

Q38297507-32418CD1-2DB5-4CE4-A7EA-F4208CF6E145

P31

Q38297507-445C3650-EAB7-40AE-AAC2-74B1AA232D66

P356

Q38297507-E925C8AB-9C77-4CE4-A7B1-93BB83501BC3

P433

Q38297507-88115CE4-BABA-47E6-99D6-57D86AA98CA3

P478

Q38297507-7352E444-8355-42C5-B116-AC1F12746ED9

P50

Q38297507-A99DCE0F-0956-4BB1-85C5-9B53727B0E8F

P577

Q38297507-06D3E95B-991D-4A02-B6C9-C7EB3F564513

P698

Q38297507-A69B2654-B72D-4F86-8593-59578F1A1868

P921

Q38297507-BE74C520-8A20-47F4-A35B-7BCF44C0F138

P932

Q38297507-55C7354E-CEA5-4A42-94E4-789C12353464

P356

J.YMGME.2014.11.017

P1433

Molecular Genetics and Metabolism

P1476

Targeting novel signaling pathways for resistant acute myeloid leukemia.

@en

P2093

Diana Saleiro

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Eklund

http://www.w3.org/2001/XMLSchema#string

John D Crispino

http://www.w3.org/2001/XMLSchema#string

Kathleen M Sakamoto

http://www.w3.org/2001/XMLSchema#string

Leonidas Platanias

http://www.w3.org/2001/XMLSchema#string

Nobuko Hijiya

http://www.w3.org/2001/XMLSchema#string

Steven Grant

http://www.w3.org/2001/XMLSchema#string

P2860

ERK1/2-dependent phosphorylation of BimEL promotes its rapid dissociation from Mcl-1 and Bcl-xL

Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1

Overexpression of HOXA10 in murine hematopoietic cells perturbs both myeloid and lymphoid differentiation and leads to acute myeloid leukemia

The ubiquitin ligase Triad1 inhibits myelopoiesis through UbcH7 and Ubc13 interacting domains

The E3 ubiquitin-protein ligase Triad1 inhibits clonogenic growth of primary myeloid progenitor cells

TRIAD1 and HHARI bind to and are activated by distinct neddylated Cullin-RING ligase complexes

mTOR signaling in growth control and disease

Recent progress toward epigenetic therapies: the example of mixed lineage leukemia

Tyrosine phosphorylation of HoxA10 decreases DNA binding and transcriptional repression during interferon gamma -induced differentiation of myeloid leukemia cell lines

ARIH2 is essential for embryogenesis, and its hematopoietic deficiency causes lethal activation of the immune system

P304

397-402

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YMGME.2014.11.017

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

114

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25533111

http://www.w3.org/2001/XMLSchema#string

P921

P932

4355162

http://www.w3.org/2001/XMLSchema#string